N,N-Dimethyltryptamine
Showing 1 - 25 of >10,000
Healthy Trial (N,N-Dimethyltryptamine (54 mg), N,N-Dimethyltryptamine (108 mg), N,N-Dimethyltryptamine (162 mg))
Recruiting
- Healthy
- N,N-Dimethyltryptamine (54 mg)
- +5 more
-
Basel, SwitzerlandUniverstity Hospital Basel
Jan 30, 2023
Healthy Trial in Basel (N,N-Dimethyltryptamine (5mg), N,N-Dimethyltryptamine (10mg), N,N-Dimethyltryptamine (15mg))
Not yet recruiting
- Healthy
- N,N-Dimethyltryptamine (5mg)
- +5 more
-
Basel, SwitzerlandClinical Pharmacology & Toxicology, University Hospital Basel
Jan 23, 2023
Depressive Disorder, Depression, Unipolar Trial in Natal (N,N-Dimethyltryptamine)
Recruiting
- Depressive Disorder
- Depression, Unipolar
- N,N-Dimethyltryptamine
-
Natal, RN, BrazilHospital Universitário Onofre Lopes
Oct 17, 2023
Safety Issues, Healthy Volunteers Trial in Natal (N,N-Dimethyltryptamine, Placebo)
Recruiting
- Safety Issues
- Healthy Volunteers
- N,N-Dimethyltryptamine
- Placebo
-
Natal, RN, BrazilHospital Universitário Onofre Lopes
Jun 2, 2023
Alcohol Use Disorder (AUD), Alcohol-Related Disorders, Alcohol Use Trial in New Haven (0.3mg/kg/min Dimethyltryptamine + Normal
Not yet recruiting
- Alcohol Use Disorder (AUD)
- +2 more
- 0.3mg/kg/min Dimethyltryptamine + Normal Saline infusion
- +2 more
-
New Haven, ConnecticutConnecticut Mental Health Center
Oct 1, 2023
Healthy Volunteers Trial in Natal (N,N-Dimethyltryptamine)
Completed
- Healthy Volunteers
- N,N-Dimethyltryptamine
-
Natal, Rio Grande Do Norte, BrazilHospital Universitário Onofre Lopes
Nov 21, 2022
Stroke Trial in Leiden (N,N-Dimethyltryptamine, Placebo)
Recruiting
- Stroke
- N,N-Dimethyltryptamine
- Placebo
-
Leiden, NetherlandsCentre for Human Drug Research
Jan 30, 2023
Chronic Low-back Pain Trial (Psilocybin therapy with Zolpidem and Modafinil, Psilocybin therapy with Zolpidem, Psilocybin
Not yet recruiting
- Chronic Low-back Pain
- Psilocybin therapy with Zolpidem and Modafinil
- +3 more
- (no location specified)
Apr 27, 2022
Pharmacokinetics, Safety, Tolerability Trial in Overland Park (5-methoxy-N,N-dimethyltryptamine succinate salt, Placebo)
Recruiting
- Pharmacokinetics
- +2 more
- 5-methoxy-N,N-dimethyltryptamine succinate salt
- Placebo
-
Overland Park, KansasAltasciences Clinical Kansas, Inc
Jan 13, 2023
Treatment-resistant Depression Trial in Galway (GH001, Placebo)
Recruiting
- Treatment-resistant Depression
- GH001
- Placebo
-
Galway, IrelandInvestigational Site
Apr 5, 2023
Generalized Anxiety Disorder Trial in Decatur (CYB004, Psychotherapy)
Not yet recruiting
- Generalized Anxiety Disorder
- CYB004
- Psychotherapy
-
Decatur, GeorgiaiResearch Atlanta
Sep 20, 2023
MDD Trial in Manchester, Liverpool (SPL026)
Recruiting
- Major Depressive Disorder
-
Manchester, Greater Manchester, United Kingdom
- +1 more
Jan 18, 2023
Healthy Volunteers Trial in Groningen (5 Methoxy N,N Dimethyltryptamine, Placebo)
Recruiting
- Healthy Volunteers
- 5 Methoxy N,N Dimethyltryptamine
- Placebo
-
Groningen, NetherlandsGH Research Clinical Trial Site
Feb 23, 2023
Emotions, Mood, Cognitive Function 1, Social Trial in Zürich (DMT, Harmine, Placebo (Harmine))
Active, not recruiting
- Emotions
- +3 more
- DMT
- +3 more
-
Zürich, SwitzerlandPsychiatric University Hospital
Nov 7, 2021
Psilocybin in Fibromyalgia: EEG-measured Brain Biomarkers of
Recruiting
- Fibromyalgia
- Psilocybin
- Therapeutic support
-
London, United KingdomImperial College London
Sep 16, 2022
Healthy Trial in Baltimore (Psilocybin, Placebo)
Recruiting
- Healthy
- Psilocybin
- Placebo
-
Baltimore, MarylandJohns Hopkins Center for Psychedelic and Consciousness Research
Aug 11, 2022
Parkinson Disease, Depression, Anxiety Trial in San Francisco (Psilocybin therapy)
Recruiting
- Parkinson Disease
- +2 more
- Psilocybin therapy
-
San Francisco, CaliforniaUniversity of California, San Francisco
Oct 25, 2022
MDD, Alcohol Use Disorder Trial in Baltimore (Psilocybin, Placebo)
Recruiting
- Major Depressive Disorder
- Alcohol Use Disorder
- Psilocybin
- Placebo
-
Baltimore, MarylandJohns Hopkins Center for Psychedelic and Consciousness Research
Aug 29, 2022
Pharmacokinetics in Healthy Adults Trial in London (BPL-003, Placebo)
Recruiting
- Pharmacokinetics in Healthy Adults
- BPL-003
- Placebo
-
London, United KingdomHammersmith Medicines Research
Apr 21, 2022
Pharmacokinetics in Healthy Adults Trial in London (5-MeO-DMT, Placebo)
Recruiting
- Pharmacokinetics in Healthy Adults
- 5-MeO-DMT
- Placebo
-
London, United KingdomKing's College London
Apr 1, 2022
Treatment Resistant Depression, MDD, Depression Trial in Maastricht (5 Methoxy N,N Dimethyltryptamine)
Completed
- Treatment Resistant Depression
- +2 more
- 5 Methoxy N,N Dimethyltryptamine
-
Maastricht, NetherlandsClinical Trial Site
Dec 6, 2021
Bipolar II Disorder Trial in San Francisco (Psilocybin therapy)
Recruiting
- Bipolar II Disorder
- Psilocybin therapy
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jan 28, 2022
Healthy Volunteers Trial in Groningen (5 Methoxy N,N Dimethyltryptamine, Placebo)
Completed
- Healthy Volunteers
- 5 Methoxy N,N Dimethyltryptamine
- Placebo
-
Groningen, NetherlandsGH Research Clinical Trial Site
Dec 13, 2021